Zafgen

- NASDAQ:ZFGN
Last Updated 2020-05-29
  • A biopharmaceutical company that develops obesity therapeutics.
  • Locations

    • Boston MA
  • Total Funding (USD)

    132.2 million
  • Industries

    Internet, Cyber Security
  • Security

    Type: ORD
    CUSIP: 98885E103
    ISIN: US98885E1038
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.